{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T11:28:27Z","timestamp":1782905307422,"version":"3.54.5"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","translationalres.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.trsl.2021.08.001","type":"journal-article","created":{"date-parts":[[2021,8,8]],"date-time":"2021-08-08T09:32:05Z","timestamp":1628415125000},"page":"18-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Circulating Mir-140 and leptin improve the accuracy of the differential diagnosis between psoriatic arthritis and rheumatoid arthritis: a case-control study"],"prefix":"10.1016","volume":"239","author":[{"given":"Sara","family":"Cheleschi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Tenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Bedogni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Fioravanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2021.08.001_bib0001","doi-asserted-by":"crossref","first-page":"65","DOI":"10.7861\/clinmedicine.17-1-65","article-title":"Psoriatic arthritis: state of the art review","volume":"17","author":"Coates","year":"2017","journal-title":"Clin Med (Lond)"},{"key":"10.1016\/j.trsl.2021.08.001_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108390","article-title":"Challenges in the clinical diagnosis of psoriatic arthritis","volume":"214","author":"Rida","year":"2020","journal-title":"Clin Immunol"},{"key":"10.1016\/j.trsl.2021.08.001_bib0003","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1001\/jama.2018.13103","article-title":"Diagnosis and management of rheumatoid arthritis: a review","volume":"320","author":"Aletaha","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.trsl.2021.08.001_bib0004","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13075-019-1898-7","article-title":"Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor\/anti-citrulline antibody-negative rheumatoid arthritis","volume":"21","author":"Alivernini","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.trsl.2021.08.001_bib0005","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/annrheumdis-2019-216374","article-title":"Differences in the serum metabolome and lipidome identify potential biomarkers for seronegative rheumatoid arthritis versus psoriatic arthritis","volume":"79","author":"Souto-Carneiro","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.trsl.2021.08.001_bib0006","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.jaci.2017.08.034","volume":"141","author":"Lu","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2021.08.001_bib0007","first-page":"518","article-title":"Do MicroRNAs have a key epigenetic role in osteoarthritis and in mechanotransduction?","volume":"35","author":"De Palma","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.trsl.2021.08.001_bib0008","first-page":"113","article-title":"Characterisation of peripheral blood mononuclear cell microRNA in early onset psoriatic arthritis","volume":"35","author":"Ciancio","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.trsl.2021.08.001_bib0009","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/7305380","article-title":"MicroRNA expression profiling in psoriatic arthritis","volume":"2018","author":"Pelosi","year":"2018","journal-title":"Biomed Res Int"},{"issue":"1","key":"10.1016\/j.trsl.2021.08.001_bib0010","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41580-018-0059-1","article-title":"Regulation of microRNA biogenesis and its crosstalk with other cellular pathways","volume":"20","author":"Treiber","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.trsl.2021.08.001_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102472","article-title":"Utility of circulating serum miRNA profiles to evaluate the potential risk and severity of immune-mediated inflammatory disorders","author":"Mart\u00ednez-Hern\u00e1ndez","year":"2020","journal-title":"J Autoimmun"},{"key":"10.1016\/j.trsl.2021.08.001_bib0012","first-page":"47","article-title":"Novel findings from determination of common expressed plasma exosomal microRNAs in patients with psoriatic arthritis, psoriasis vulgaris, rheumatoid arthritis, and gouty arthritis","volume":"28","author":"Chen","year":"2019","journal-title":"Discov Med"},{"key":"10.1016\/j.trsl.2021.08.001_bib0013","article-title":"MiR-146a-5p expression in peripheral CD14\u207a monocytes from patients with psoriatic arthritis induces osteoclast activation, bone resorption, and correlates with clinical response","volume":"8","author":"Lin","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.trsl.2021.08.001_bib0014","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.3899\/jrheum.190602","article-title":"Serum microRNA signature as a diagnostic and therapeutic marker in patients with psoriatic arthritis","volume":"47","author":"Wade","year":"2020","journal-title":"J Rheumatol"},{"key":"10.1016\/j.trsl.2021.08.001_bib0015","doi-asserted-by":"crossref","unstructured":"Pasquali L, Svedbom A, Srivastava A, et\u00a0al. Circulating microRNAs in extracellular vesicles as potential biomarkers for psoriatic arthritis in patients with psoriasis. 2020;34:1248-56. doi:10.1111\/jdv.16203.","DOI":"10.1111\/jdv.16203"},{"key":"10.1016\/j.trsl.2021.08.001_bib0016","first-page":"400","article-title":"High degree of correlation between whole blood and PBMC expression levels of miR-155 and miR-146a in healthy controls and rheumatoid arthritis patients","author":"Mookherjee","year":"2013","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.trsl.2021.08.001_bib0017","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1136\/annrheumdis-2012-202815","article-title":"Association of circulating miR-223 and miR-16 with disease activity in patients with early rheumatoid arthritis","volume":"73","author":"Filkov\u00e1","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.trsl.2021.08.001_bib0018","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/cei.13156","article-title":"Circulating serum miR-223-3p and miR-16-5p as possible biomarkers of early rheumatoid arthritis","volume":"193","author":"Dunaeva","year":"2018","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.trsl.2021.08.001_bib0019","doi-asserted-by":"crossref","first-page":"e22953","DOI":"10.1002\/jcla.22953","article-title":"Correlation of microRNA expression profile with clinical response to tumor necrosis factor inhibitor in treating rheumatoid arthritis patients: a prospective cohort study","volume":"33","author":"Liu","year":"2019","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.trsl.2021.08.001_bib0020","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/nrrheum.2016.49","article-title":"Adipokines in bone disease","volume":"12","author":"Neumann","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.trsl.2021.08.001_bib0021","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20174091","article-title":"The adipokine network in rheumatic joint diseases","volume":"20","author":"Carri\u00f3n","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.trsl.2021.08.001_bib0022","first-page":"1044","article-title":"Circulating levels of the adipokines vaspin and omentin in patients with juvenile idiopathic arthritis, and relation to disease activity","volume":"29","author":"Cantarini","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.trsl.2021.08.001_bib0023","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1007\/s00296-011-1873-3","article-title":"Circulating levels of the adipocytokines vaspin and omentin in patients with Kawasaki disease","volume":"32","author":"Fioravanti","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.trsl.2021.08.001_bib0024","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1080\/03009742.2016.1188981","article-title":"Increased serum leptin and visfatin levels in patients with diffuse idiopathic skeletal hyperostosis: a comparative study","volume":"46","author":"Tenti","year":"2017","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.trsl.2021.08.001_bib0025","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/1354750X.2017.1401665","article-title":"Can adipokines serum levels be used as biomarkers of hand osteoarthritis?","volume":"23","author":"Fioravanti","year":"2018","journal-title":"Biomarkers"},{"key":"10.1016\/j.trsl.2021.08.001_bib0026","first-page":"293","article-title":"Tocilizumab modulates serum levels of adiponectin and chemerin in patients with rheumatoid arthritis: potential cardiovascular protective role of IL-6 inhibition","volume":"37","author":"Fioravanti","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.trsl.2021.08.001_bib0027","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s00393-016-0050-1","article-title":"Circulating leptin level in rheumatoid arthritis and its correlation with disease activity: a meta-analysis","volume":"75","author":"Lee","year":"2016","journal-title":"Z Rheumatol"},{"key":"10.1016\/j.trsl.2021.08.001_bib0028","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1080\/08916934.2016.1230847","article-title":"Baseline adiponectin and leptin levels in predicting an increased risk of disease activity in rheumatoid arthritis: a meta-analysis and systematic review","volume":"49","author":"Cao","year":"2016","journal-title":"Autoimmunity"},{"key":"10.1016\/j.trsl.2021.08.001_bib0029","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/1756-185X.13038","article-title":"Circulating adiponectin and visfatin levels in rheumatoid arthritis and their correlation with disease activity: a meta-analysis","volume":"21","author":"Lee","year":"2018","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.trsl.2021.08.001_bib0030","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3389\/fmed.2018.00207","article-title":"Chemerin and PEDF are metaflammation-related biomarkers of disease activity and obesity in rheumatoid arthritis","volume":"5","author":"Tolusso","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.trsl.2021.08.001_bib0031","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.3390\/ijms20061505","article-title":"Associations between adipokines in arthritic disease and implications for obesity","volume":"20","author":"M\u1d43\u1d9cDonald","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.trsl.2021.08.001_bib0032","doi-asserted-by":"crossref","first-page":"e46740","DOI":"10.1371\/journal.pone.0046740","article-title":"Adipokines in psoriatic arthritis patients: the correlations with osteoclast precursors and bone erosions","volume":"7","author":"Xue","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2021.08.001_bib0033","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1136\/annrheumdis-2012-202325","article-title":"Serum adipokines in patients with psoriatic arthritis and psoriasis alone and their correlation with disease activity","volume":"72","author":"Eder","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.trsl.2021.08.001_bib0034","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/1756-185X.12444","article-title":"Serum levels of visfatin, resistin and adiponectin in patients with psoriatic arthritis and associations with disease severity","volume":"19","author":"Dikbas","year":"2016","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.trsl.2021.08.001_bib0035","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/RHU.0000000000000721","article-title":"Increased prevalence of metabolic syndrome and adipocytokine levels in a psoriatic arthritis cohort","volume":"24","author":"Feld","year":"2018","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.trsl.2021.08.001_bib0036","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1007\/s10067-019-04619-w","article-title":"Pro-inflammatory adipokine profile in psoriatic arthritis: results from a cross-sectional study comparing PsA subset with evident cutaneous involvement and subset \"sine psoriasis\"","volume":"38","author":"Caso","year":"2019","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.trsl.2021.08.001_bib0037","first-page":"keaa720","article-title":"Visceral adiposity in patients with psoriatic arthritis and psoriasis alone and its relationship with metabolic and cardiovascular risk","author":"Toussirot","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.trsl.2021.08.001_bib0038","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis: development of new criteria from a large international study","volume":"54","author":"Taylor","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.trsl.2021.08.001_bib0039","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.trsl.2021.08.001_bib0040","series-title":"Anthropometric standardization reference manual","author":"Lohman","year":"1991"},{"issue":"Suppl 2","key":"10.1016\/j.trsl.2021.08.001_bib0041","first-page":"51S","article-title":"Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. the evidence report. national institutes of health","volume":"6","author":"Health","year":"1998","journal-title":"Obes Res"},{"key":"10.1016\/j.trsl.2021.08.001_bib0042","doi-asserted-by":"crossref","unstructured":"Executive summary of the third report of the national cholesterol education program (NCEP) (2001) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285:2486\u201397.","DOI":"10.1001\/jama.285.19.2486"},{"key":"10.1016\/j.trsl.2021.08.001_bib0043","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1477-7525-1-20","article-title":"The Stanford Health Assessment Questionnaire: dimensions and practical applications","volume":"1","author":"Bruce","year":"2003","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.trsl.2021.08.001_bib0044","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/rheumatology\/32.7.589","article-title":"Validity and reliability of joint indices. a longitudinal study in patients with recent onset rheumatoid arthritis","volume":"32","author":"Prevoo","year":"1993","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.trsl.2021.08.001_bib0045","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s10067-014-2626-y","article-title":"Remission criteria and activity indices in psoriatic arthritis","volume":"33","author":"Acosta Felquer","year":"2014","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.trsl.2021.08.001_bib0046","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000250839","article-title":"Severe psoriasis \u2013 oral therapy with a new retinoid","volume":"157","author":"Fredriksson","year":"1978","journal-title":"Dermatologica"},{"key":"10.1016\/j.trsl.2021.08.001_bib0047","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1136\/ard.2004.030213","article-title":"Absence of anti-cyclic citrullinated peptide antibodies in erosive osteoarthritis: further serological evidence of the disease as a subset of osteoarthritis","volume":"64","author":"Morozzi","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.trsl.2021.08.001_bib0048","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/2363460","article-title":"Exploring the Involvement of NLRP3 and IL-1\u03b2 in Osteoarthritis of the hand: results from a pilot study","volume":"2019","author":"Fioravanti","year":"2019","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.trsl.2021.08.001_bib0049","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.3390\/ijms21103653","article-title":"Hydrostatic pressure regulates oxidative stress through microRNA in human osteoarthritic chondrocytes","volume":"21","author":"Cheleschi","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.trsl.2021.08.001_bib0050","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0304-3940(02)01423-4","article-title":"Assumption-free analysis of quantitative real-timepolymerase chain reaction (PCR) data","volume":"339","author":"Ramakers","year":"2003","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.trsl.2021.08.001_bib0051","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1177\/1536867X1301300208","article-title":"Exact Wilcoxon signed-rank and Wilcoxon Mann\u2013Whitney ranksum tests","volume":"13","author":"Harris","year":"2013","journal-title":"Stata J"},{"key":"10.1016\/j.trsl.2021.08.001_bib0052","series-title":"Clinical prediction models","author":"Steyerberg","year":"2019"},{"key":"10.1016\/j.trsl.2021.08.001_bib0053","series-title":"Multivariable model-building: a pragmatic approach to regression analysis based on fractional polynomials for modelling continuous variables","author":"Royston","year":"2008"},{"key":"10.1016\/j.trsl.2021.08.001_bib0054","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1177\/1536867X0900900204","article-title":"Two techniques for investigating interactions between treatment and continuous covariates in clinical trials","volume":"9","author":"Royston","year":"2009","journal-title":"Stata J"},{"key":"10.1016\/j.trsl.2021.08.001_bib0055","series-title":"Applied linear regression","author":"Weisberg","year":"2014"},{"issue":"8","key":"10.1016\/j.trsl.2021.08.001_bib0056","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/ard.2004.032177","article-title":"Anti-citrullinated peptide antibodies may occur in patients with psoriatic arthritis","volume":"64","author":"Vander Cruyssen","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.trsl.2021.08.001_bib0057","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2018-000656","article-title":"Distinguishing rheumatoid arthritis from psoriatic arthritis","volume":"4","author":"Merola","year":"2018","journal-title":"RMD Open"},{"key":"10.1016\/j.trsl.2021.08.001_bib0058","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.3390\/ijms22052719","article-title":"The role of tumor necrosis factor alpha (TNF-\u03b1) in autoimmune disease and current TNF-\u03b1 inhibitors in therapeutics","volume":"22","author":"Jang","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.trsl.2021.08.001_bib0059","article-title":"IL-23 inhibition for the treatment of psoriatic arthritis","author":"Mohanakrishnan","year":"2021","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.trsl.2021.08.001_bib0060","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1111\/1756-185X.13202","article-title":"Role of microRNA-155 in rheumatoid arthritis","volume":"20","author":"Su","year":"2017","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.trsl.2021.08.001_bib0061","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1111\/1756-185X.13338","article-title":"MiR-146a levels in rheumatoid arthritis and their correlation with disease activity: a meta-analysis","volume":"21","author":"Bae","year":"2018","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.trsl.2021.08.001_bib0062","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2019.102391","article-title":"MicroRNAs in rheumatoid arthritis: From pathogenesis to clinical impact","volume":"18","author":"Evangelatos","year":"2019","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.trsl.2021.08.001_bib0063","article-title":"Implications of microRNA 21 and its involvement in the treatment of different type of arthritis","author":"Sekar","year":"2020","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.trsl.2021.08.001_bib0064","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106404","article-title":"Altered expression of microRNAs may predict therapeutic response in rheumatoid arthritis patients","volume":"83","author":"Rezaeepoor","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.trsl.2021.08.001_bib0065","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s10020-020-00199-7","article-title":"Serum a proliferation-inducing ligand and MicroRNA-223 are associated with rheumatoid arthritis: diagnostic and prognostic implications","volume":"26","author":"Taha","year":"2020","journal-title":"Mol Med"},{"key":"10.1016\/j.trsl.2021.08.001_bib0066","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3899\/jrheum.181029","article-title":"Development and validation of a microRNA panel to differentiate between patients with rheumatoid arthritis or systemic lupus erythematosus and controls","volume":"47","author":"Ormseth","year":"2020","journal-title":"J Rheumatol"},{"key":"10.1016\/j.trsl.2021.08.001_bib0067","doi-asserted-by":"crossref","first-page":"e73604","DOI":"10.1371\/journal.pone.0073604","article-title":"miR-140 suppresses tumor growth and metastasis of non-small cell lung cancer by targeting insulin-like growth factor 1 receptor","volume":"8","author":"Yuan","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2021.08.001_bib0068","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s13148-017-0428-1","article-title":"Serum microRNA array analysis identifies miR-140-3p, miR-33b-3p and miR-671-3p as potential osteoarthritis biomarkers involved in metabolic processes","volume":"9","author":"Ntoumou","year":"2017","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.trsl.2021.08.001_bib0069","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.3390\/ijms19123909","article-title":"A Complex Relationship between visfatin and resistin and microRNA: an in vitro study on human chondrocyte cultures","volume":"19","author":"Cheleschi","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.trsl.2021.08.001_bib0070","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/art.39446","article-title":"Amelioration of experimental autoimmune arthritis through targeting of synovial fibroblasts by intraarticular delivery of microRNAs 140-3p and 140-5p","volume":"68","author":"Peng","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.trsl.2021.08.001_bib0071","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1136\/ard.2010.148957","article-title":"SIRT1 overexpression in the rheumatoid arthritis synovium contributes to proinflammatory cytokine production and apoptosis resistance","volume":"70","author":"Niederer","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.trsl.2021.08.001_bib0072","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.bbrc.2011.07.048","article-title":"MicroRNA-22 and microRNA-140 suppress NF-\u03baB activity by regulating the expression of NF-\u03baB coactivators","volume":"411","author":"Takata","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.trsl.2021.08.001_bib0073","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/hep.26315","article-title":"MicroRNA-140-5p suppresses tumor growth and metastasis by targeting transforming growth factor \u03b2 receptor 1 and fibroblast growth factor 9 in hepatocellular carcinoma","volume":"58","author":"Yang","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.trsl.2021.08.001_bib0074","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317697558","article-title":"MicroRNA-140-5p inhibits cell proliferation and invasion by regulating VEGFA\/MMP2 signaling in glioma","volume":"39","author":"Hu","year":"2017","journal-title":"Tumour Biol"},{"key":"10.1016\/j.trsl.2021.08.001_bib0075","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/2761241","article-title":"pNNS-conjugated chitosan mediated IGF-1 and miR-140 overexpression in articular chondrocytes improves cartilage repair","volume":"2019","author":"Zhao","year":"2019","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.trsl.2021.08.001_bib0076","first-page":"839","article-title":"MicroRNA-140-5p aggravates hypertension and oxidative stress of atherosclerosis via targeting Nrf2 and Sirt2","volume":"43","author":"Liu","year":"2019","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.trsl.2021.08.001_bib0077","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-020-03726-1","article-title":"Immune responses and therapeutic options in psoriasis","author":"Afonina","year":"2021","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.trsl.2021.08.001_bib0078","doi-asserted-by":"crossref","DOI":"10.1111\/1346-8138.15727","article-title":"Psoriasis: recent progress in molecular-targeted therapies","author":"Honma","year":"2021","journal-title":"J Dermatol"},{"key":"10.1016\/j.trsl.2021.08.001_bib0079","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/exd.13520","article-title":"The contribution of feedback loops between miRNAs, cytokines and growth factors to the pathogenesis of psoriasis","volume":"27","author":"Masalha","year":"2018","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.trsl.2021.08.001_bib0080","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1080\/14728222.2019.1617274","article-title":"Visfatin as a therapeutic target for rheumatoid arthritis","volume":"23","author":"Franco-Trepat","year":"2019","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.trsl.2021.08.001_bib0081","doi-asserted-by":"crossref","first-page":"67","DOI":"10.5114\/reum.2020.95359","article-title":"Serum chemerin and visfatin levels and their ratio as possible diagnostic parameters of rheumatoid arthritis","volume":"58","author":"Mohammed Ali","year":"2020","journal-title":"Reumatologia"},{"key":"10.1016\/j.trsl.2021.08.001_bib0082","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1080\/03009742.2020.1753808","article-title":"Elevated adiponectin predicts the development of rheumatoid arthritis in subjects with obesity","volume":"49","author":"Zhang","year":"2020","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.trsl.2021.08.001_bib0083","article-title":"The contribution of adipokines to joint inflammation in inflammatory rheumatic diseases","volume":"11","author":"Mini-Review","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.trsl.2021.08.001_bib0084","doi-asserted-by":"crossref","first-page":"8265","DOI":"10.3390\/ijms21218265","article-title":"Role of adiponectin in the pathogenesis of rheumatoid arthritis","volume":"21","author":"Szumilas","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.trsl.2021.08.001_bib0085","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4062\/biomolther.2020.054","article-title":"The role of leptin in the association between obesity and psoriasis","volume":"29","author":"Hwang","year":"2021","journal-title":"Biomol Ther (Seoul)"},{"key":"10.1016\/j.trsl.2021.08.001_bib0086","doi-asserted-by":"crossref","first-page":"6820","DOI":"10.4049\/jimmunol.174.11.6820","article-title":"Leptin promotes differentiation and survival of human dendritic cells and licenses them for Th1 priming","volume":"174","author":"Mattioli","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2021.08.001_bib0087","first-page":"471","article-title":"Leptin and adiponectin as predictors of disease activity in rheumatoid arthritis","volume":"33","author":"Xibill\u00e9-Friedmann","year":"2015","journal-title":"Clin Exp Rheumatol"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524421001912?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524421001912?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T12:45:04Z","timestamp":1761828304000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524421001912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":87,"alternative-id":["S1931524421001912"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2021.08.001","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating Mir-140 and leptin improve the accuracy of the differential diagnosis between psoriatic arthritis and rheumatoid arthritis: a case-control study","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2021.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}